It has been shown that miR-129-5p was deregulated in several tumor types including endometrial cancer, esophageal cancer, colon cancer and bladder cancer, and its verified target genes included SOX4 [15]–[17], VCP/p97 [18] and Cdk6 [19]. This evidence concerns the gene SOX4 and urinary bladder cancer.